BANGKOK (Reuters): Thailand's Food and Drug Administration (FDA) has granted emergency use approval for the Covid-19 vaccine of AstraZeneca, three health ministry sources said on Thursday (Jan 21).
Thailand is set to import 200,000 doses of the AstraZeneca vaccine, with the first 50,000 doses expected to arrive next month, Health Minister Anutin Charnvirakul said on Wednesday.
The three senior ministry sources, who requested anonymity because they were not authorised to speak to media, said the regulator had approved the AstraZeneca vaccine on Wednesday, applicable for a period of one year.
One of the sources said approval applied only to doses manufactured overseas.
Thailand has signed a deal with AstraZeneca to produce 26 million doses of its vaccine locally through the firm Siam Bioscience.
Thailand's FDA has so far received registration requests for vaccines from AstraZeneca and China's Sinovac Biotech.
Did you find this article insightful?
100% readers found this article insightful
